Nimika 250mg Injection
Marketer
Elfin Pharma Pvt Ltd
Salt Composition
Amikacin (250mg)
Overview Nimika 250mg Injection
Cefuroxime 250mg Injection combats a broad spectrum of bacterial infections, encompassing urinary tract, bone, joint, lung (pneumonia), brain, and bloodstream infections, among others. Prophylactically, it's administered to hospitalized individuals to preempt infections. This antibiotic functions by inhibiting bacterial proliferation. Administered intravenously (IV drip) or intramuscularly by a healthcare professional, self-injection is strictly prohibited. Adhere to the prescribed dosage schedule, completing the entire course regardless of symptom improvement. Premature cessation risks infection recurrence or exacerbation. Typical side effects include injection site inflammation and elevated blood urea nitrogen. Persistent side effects or treatment ineffectiveness warrant immediate medical consultation. High doses may induce vertigo, nephrotoxicity, and ototoxicity. Close adherence to physician instructions is crucial, including potential monitoring via kidney function, hearing, and urinalysis. Its use during pregnancy is contraindicated; disclose pregnancy, pregnancy planning, or breastfeeding to your doctor.
Primary Ingredients of Nimika 250mg Injection
No text provided to rephrase.
Uses of Nimika 250mg Injection
Infections caused by bacteria
Major Benefits of Nimika 250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Nimika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Nimika 250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Nimika 250mg Injection works:
Nimika 250mg injection is a bacterial growth inhibitor, functioning as an antibiotic by blocking the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Nimika 250mg Injection does not interact negatively with alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Nimika 250mg Injection during pregnancy carries established risks to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use justified if the potential advantages outweigh the hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The 250mg Nimika Injection presents minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, posing no discernible harm to the infant.
DrivingUNSAFE
Administering Nimika 250mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCAUTION
For individuals with impaired kidney function, administering Nimika 250mg Injection requires careful consideration. Dosage modification of Nimika 250mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Nimika 250mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Nimika 250mg Injection :
Should you forget a scheduled Nimika 250mg Injection, seek your physician's advice.
Facts to Know About Nimika 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
3,018 People bought this recently